author-photo

Aude Charbonnier

French Institute of Health and Medical Research

119

Papers

1555

Citations

Citation Trend

Filter By

Papers (80) Sort By

Journal Conference Others

Treatment-Free Remission (TFR) after Two Different Durations of Nilotinib Consolidation in Patients with Chronic Myeloid Leukemia (CML) Previously Treated with Imatinib: Enestpath Study Results

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute’s Experience

2021 CHI | Human Factors in Computing Systems
Show All
- Source
- Cite
- Save
Citations (0)
An Update of Safety and Efficacy Results from Phase 1 Dose-Escalation and Expansion Study of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI), in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Failing Prior TKI Therapies

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients

2021 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (3)
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines

2020 Journal of the American Heart Association
Show All
- Source
- Cite
- Save
Citations (25)
Socioeconomic deprivation is associated with decreased survival in patients with acute myeloid leukemia

2020 Cancer Epidemiology
Show All
- Source
- Cite
- Save
Citations (3)
Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.

2020 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (4)
Corrigendum to "Socioeconomic deprivation is associated with decreased survival in patients with acute myeloid leukemia" [Cancer Epidemiol. 66 (2020) 101699].

2020 Cancer Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib

2020 Blood
Show All
- Source
- Cite
- Save
Citations (7)
CML-277: Efficacy of Bosutinib in Imatinib-Resistant vs Dasatinib/Nilotinib-Resistant Chronic Phase Chronic Myeloid Leukemia: Results from the Phase 4 BYOND Study

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)